NEUP (Neuphoria Therapeutics Inc.) Projected Sales Volume

Official company branding of Neuphoria Therapeutics (NEUP)

Neuphoria Therapeutics Inc. (NEUP) is developing antidepressants with stable demand regardless of economic cycles. Diversification through targeted molecules expands its presence in psychiatry, although regulatory complexities and losses create capital risks. The future sales trajectory of Neuphoria Therapeutics Inc. (NEUP) on GURU.Markets analytics helps identify anomalies, while 0.00 represents the latest metric reading.

NEUP - Neuphoria Therapeutics Projected Sales Volume over the range 12/25/2024 - 11/18/2026

Comprehensive metric breakdowns and analytics for Neuphoria Therapeutics Inc. (NEUP)

Fundamental valuation:Neuphoria Therapeutics
Product sample of Neuphoria

For Neuphoria Therapeutics Inc. (NEUP), the target sales dynamics reflect the expected revenue from the commercialization of PTSD treatments. This metric measures capital density by comparing current investments with projected earnings. The calculation is based on the deviation of actual demand from management's implementation plans. For this R&D company, the upward trend confirms the successful navigation of regulatory barriers. Investors should view this trend as an indicator of the transition from clinical trials to market expansion.

Competitors of Neuphoria Therapeutics Inc. (NEUP)

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue Annovis Bio Corp ANVS|GRCE: Company Revenue Forecast|AIFF - Company Projected Revenue|KLTO (anewmeds.com) - Company Revenue Forecast|NRSN (NeuroSense Therapeutics Ltd.) - Company Future Sales Volume|revivapharma.com - Company Future Revenue|MTVA (metaviatx.com) - Projected Sales Volume|NRXS: Company Future Revenue|Projected Sales Volume HSDT|PASG - Company Expected Sales Volume|Company Projected Revenue Minerva Neurosciences, Inc. NERV|Projected Sales Volume Athira Pharma ATHA|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics